Publication | Closed Access

Lenalidomide in relapsed adult T-cell leukaemia-lymphoma or peripheral T-cell lymphoma (ATLL-001): a phase 1, multicentre, dose-escalation study

Dose-escalation StudyLymphoid NeoplasiaHematological MalignancyMedicinePeripheral T-cell LymphomaHematologyImmunologyPathologyAdult T-cell Leukemia-lymphomaImmunotherapyOncologyRadiation OncologyPhase 1Cancer ResearchHealth Sciences